Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03006718 · ClinicalTrials.gov registry record · NA
SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain
A NA study, sponsored by Julia Finkel.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT03006718 is a NA study that has completed, run by Julia Finkel. The registered enrollment target is 150 participants.
The verdict
NCT03006718, a NA study, has completed, sponsored by Julia Finkel.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The overall goal of the project is to reduce pain-related, 30-day readmission rates for sickle cell disease (SCD) patients. The investigators want to see if a mobile phone application (app) can help decrease the need for repeat admission to the hospital because of sickle cell pain.
Interventions
- OTHER PROMIS for Pain Management App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03006718
The ClinicalTrials.gov registry entry for NCT03006718 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Julia Finkel, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PROMIS for Pain Management App is the first listed.
NCT03006718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03006718 about?
NCT03006718 is a clinical study titled "SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain". The overall goal of the project is to reduce pain-related, 30-day readmission rates for sickle cell disease (SCD) patients. The investigators want to see if a mobile phone application (app) can help decrease the need for repeat admission to the hospital because of sickle cell pain.
What is the current status of trial NCT03006718?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2016-11. Estimated completion is 2019-09.
What interventions are being tested in trial NCT03006718?
The interventions under investigation include: PROMIS for Pain Management App (OTHER).
Who is sponsoring clinical trial NCT03006718?
This trial is sponsored by Julia Finkel, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.